Brockmeier Achim, Brockmeier Ulf, Williams David B
Department of Biochemistry and Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
J Biol Chem. 2009 Feb 6;284(6):3433-44. doi: 10.1074/jbc.M804866200. Epub 2008 Dec 12.
Calnexin is a Ca2+-binding transmembrane chaperone of the endoplasmic reticulum that recognizes Glc1Man5-9GlcNAc2 oligosaccharides on folding glycoproteins as well as non-native elements of the polypeptide backbone. This latter mode of recognition enables calnexin to suppress the aggregation of both glycosylated and nonglycosylated substrates. The luminal portion of calnexin (S-Cnx) consists of two domains, a globular lectin domain and an extended arm domain. To understand the function of these domains during the interaction of calnexin with non-native protein conformers, we tested deletion mutants of S-Cnx for their abilities to suppress the aggregation of nonglycosylated firefly luciferase. The arm domain alone exhibited no capacity to suppress aggregation. However, stepwise truncation of the arm domain in S-Cnx resulted in a progressive reduction in aggregation suppression potency to the point where the globular domain alone exhibited 25% potency. To characterize the polypeptide-binding site, we used hydrophobic peptides that were competitors of the ability of S-Cnx to suppress luciferase aggregation. Direct binding experiments revealed a single site of peptide binding in the globular domain (Kd = 0.9 microm) at a location distinct from the lectin site. Progressive truncation of the arm domain in S-Cnx had no effect on the binding of small peptides but reduced the binding affinity of S-Cnx for large, non-native protein substrates. Because protein substrates exhibited no binding to the isolated arm domain, our findings support a model in which calnexin suppresses aggregation through a polypeptide-binding site in its globular domain, with the arm domain enhancing aggregation suppression by sterically constraining large substrates.
钙连蛋白是内质网中一种结合钙离子的跨膜伴侣蛋白,它能识别折叠糖蛋白上的Glc1Man5-9GlcNAc2寡糖以及多肽主链的非天然元件。后一种识别模式使钙连蛋白能够抑制糖基化和非糖基化底物的聚集。钙连蛋白的腔内部分(S-Cnx)由两个结构域组成,一个球状凝集素结构域和一个延伸的臂状结构域。为了了解这些结构域在钙连蛋白与非天然蛋白质构象体相互作用过程中的功能,我们测试了S-Cnx的缺失突变体抑制非糖基化萤火虫荧光素酶聚集的能力。单独的臂状结构域没有抑制聚集的能力。然而,S-Cnx中臂状结构域的逐步截短导致聚集抑制效力逐渐降低,直至仅球状结构域表现出25%的效力。为了表征多肽结合位点,我们使用了疏水肽,它们是S-Cnx抑制荧光素酶聚集能力的竞争者。直接结合实验揭示了在球状结构域中有一个单一的肽结合位点(解离常数Kd = 0.9微摩尔),其位置与凝集素位点不同。S-Cnx中臂状结构域的逐步截短对小肽的结合没有影响,但降低了S-Cnx对大的非天然蛋白质底物的结合亲和力。由于蛋白质底物与分离的臂状结构域没有结合,我们的研究结果支持了一个模型,即钙连蛋白通过其球状结构域中的多肽结合位点抑制聚集,臂状结构域通过空间上限制大的底物来增强聚集抑制作用。